Close
Xylem
Novotech

Getinge Selects Anaqua to Provide Single, Centralized IP Management Platform

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Quantum Computing Advancing Molecular Discovery Models

Harnessing the power of subatomic physics to simulate complex biological interactions at an atomic level, unlocking new frontiers in drug discovery and precision medicine through unprecedented computational speed.

Digital Therapeutics Expanding Pharmaceutical Care

Redefining patient treatment through clinically validated software interventions that complement or replace traditional medications, offering personalized, remote, and scalable care for chronic conditions.

Knowledge Graphs Improving Pharmaceutical Intelligence

Connecting disparate datasets into a unified semantic network to uncover hidden relationships between diseases, drugs, and genetic markers, accelerating discovery and operational decision-making.
- Advertisement -

Anaqua, the leading innovation and intellectual property (IP) management technology provider announced that global medical technology company Getinge has selected Anaquaโ€™s AQX in order to consolidate the management of all its IP assets onto a single, centralized platform.

Founded in Sweden in 1904, Getinge provides hospitals and life science institutions in 133 countries with products and solutions that aim to improve clinical results and optimize workflows.

Anna Maria Lagerqvist Gahm,ย Head of IP & Digital Law at Getinge, said:ย โ€œWith our extensive range of products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing, life science and digital healthcare solutions and our strong international presence with operations in more than 40 countries worldwide, it was important to be able to improve the efficiency and coordination of our IP management by consolidating onto a centralized platform. AQX enables us to do that, while also providing highly integrated functionality in key areas such as analytics and invention management.โ€

Bob Romeo, CEO of Anaqua, said:ย โ€œGetinge focuses on helping its customers save lives through the products and solutions it develops, and on achieving its goal of becoming the worldโ€™s most trusted and respected medtech company. We are delighted to be supporting Getinge on that journey by helping manage and protect the companyโ€™s valuable IP assets. Anaqua continues to invest in offerings to meet and exceed the ever-evolving demands of the worldโ€™s most innovative life science companies.โ€

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Quantum Computing Advancing Molecular Discovery Models

Harnessing the power of subatomic physics to simulate complex biological interactions at an atomic level, unlocking new frontiers in drug discovery and precision medicine through unprecedented computational speed.

Digital Therapeutics Expanding Pharmaceutical Care

Redefining patient treatment through clinically validated software interventions that complement or replace traditional medications, offering personalized, remote, and scalable care for chronic conditions.

Knowledge Graphs Improving Pharmaceutical Intelligence

Connecting disparate datasets into a unified semantic network to uncover hidden relationships between diseases, drugs, and genetic markers, accelerating discovery and operational decision-making.

Digital Product Passports Enhancing Pharma Traceability

Revolutionizing pharmaceutical supply chains through decentralized digital identities that track drug lifecycles from manufacturing to patient delivery, ensuring authenticity and regulatory compliance.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป